期刊文献+

血管性血友病因子vWF73和vWF114片段的表达及其在ADAMTS13活性测定中的应用

Expression of vWF73 and vWFll4 fragments of von Willebrand factor A2 domain and their utilization in detecting
原文传递
导出
摘要 目的构建血管性血友病因子(vWF)A2区片段vWF73和vWF114的表达质粒,在大肠杆菌中表达两种谷胱甘肽S转移酶(GST)融合蛋白,并探讨两种蛋白作为底物在测定ADAMTS13活性中的应用价值。方法应用PCR的方法扩增vWFA2区内vWF73和vWF114的相应DNA片段,分别克隆至GST融合表达载体pGEX-6P-1进行诱导表达,Ni—NTA琼脂糖柱纯化可溶性蛋白部分。以Western blot法检测正常人血浆、血栓性血小板减少性紫癜(TTP)患者血浆和重组ADAMTS13(rADAMTS13)水解两种重组vWFA2区片段的情况,并以此为底物用抗GST和抗His两种抗体建立酶联免疫吸附试验(ELISA)法测定血浆ADAMTS13活性的新方法。结果成功表达和纯化了ADAMTS13的两种可溶性小分子底物GST—vWF73-H和GST—vWF114-H,均能被rADAMTS13或正常人血浆有效地水解,而遗传性和特发性ttP患者血浆则无此作用。同时,以此为底物建立了测定ADAMTS13活性的ELISA方法。结论采用原核表达系统成功得到了vWFA2区片段vWF73和vWF114两种GST融合蛋白,可作为底物用于ADAMTS13活性的测定。 Objective To construct the expression vectors of vWF73 and vWF114 fragments of von Willebrand factor (vWF) A2 domain, and to express glutathione S-transferase (GST) fusion proteins in E. coli, and to explore their values in measuring ADAMTSI 3 activity as substrates. Methods The DNA fragments encoding vWF73 and vWF114 were generated using PCR and separately cloned into pGEX-6P-1, a Schistosoma japonicum GST fusion expression vector. The expression of GST-vWF73-H and GST-vWF114-H was induced in liquid culture, followed by purification with Ni-NTA agarose column. The cleavage of two GST fusion proteins by recombinant ADAMTS13 (rADAMTS13) or plasma from normal individuals and thrombotic thromboeytopenic purpura (TFP) patients were identified by Western blot. Based on an enzyme-linked immunosorbent assay (ELISA) with anti-GST and anti-His monoclonal antibodies, GST-vWF73-H and GST- vWFll4-H were used to measure plasma ADAMTS13 activity as substrates. Results Two small molecular substrates of ADAMTS13, GST-vWF73-H and GST-vWF114-H, are expressed and purified,which could be specifically cleaved by rADAMTSI3 or plasma from healthy individuals, but not by plasma from congenital or idiopathic TTP patients. An ELISA assay was established to detect plasma ADAMTS13 activity using GST- vWF73-H and GST-vWF114-H as substrates. Conclusions Two GST fusion proteins in vWF A2 domain, vWF73 and vWF114, were expressed effectively using a prokaryotic expression system and could be used to detect ADAMTS13 activity as substrates.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2011年第5期337-341,共5页 Chinese Journal of Hematology
基金 国家自然科学基金(30670904)
关键词 血管性血友病因子 融合蛋白 血管性血友病因子裂解酶 紫癜 血栓性血小板减少性 yon Willebrand factor Fusion protein ADAMTS13 Purpura, thrombotic thrombocytopenic
  • 相关文献

参考文献13

  • 1Hnvinga JA, Vesely SK, Terrell DR, et al. Survival and relapse in patients with thrombotic thromboeytopenic purpura. Blood, 2010, 115: 1500-1511.
  • 2Furlan M, Rohles R, Solenthaler M, et al. Deficient activity of yon Willebrand factor-cleaving protease in chronic relapsing throm- botic thrombocytopenic purpura. Blood, 1997, 89: 3097-5103.
  • 3Furlan M, Robles R, Galbusera M, et al. Von Willebrand factor- cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med, 1998, 339: 1578- 1584.
  • 4Tsai HM, Lian EC. Antibodies to yon Willebrand factor cleaving protease in acute thrombotic thrombocytopenie purpura. N Engl J Med, 1998, 339: 1585-1594.
  • 5Sadler JE. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood, 2008, 112 : 11-18.
  • 6Zheng XL, Sadler JE. Pathogenesis of thrombotic microangiopa- thies. Annu Rev Pathol Mech Dis, 2008, 3: 249-277.
  • 7Mahdian R, Rayes J, Girma JP, et al. Comparison of FRETS- vWF73 to full-length vWF as a substrate for ADAMTSI3 activity measurement in human plasma samples. Thromb Haemost, 2006, 95 : 1049-1051.
  • 8Shelat SG, Ai J, Zheng XL. Molecular biology of ADAMTS13 and diagnostic utility of ADAMTS13 proteolytic activity and inhibitor assays. Semin Thromb Hemost, 2005, 31 : 659-672.
  • 9Tripodi A, Peyvandi F, Chantarangkul V, et al. Second interna- tional collaborative study evaluating performance characteristics of methods measuring the yon Willebrand factor cleaving protease (ADAMTS-13). J Thromb Haemost, 2008, 6 : 1534-1541.
  • 10Zhou W, Tsai HM. An enzyme immunoassay of ADAMTS13 dis- tinguishes patients with thrombotic thrombocytopenic purpura from normal individuals and carriers of ADAMTS13 mutations. Thromb Haemost, 2004, 91 : 806-811.

二级参考文献11

  • 1Dong JF. Structural and functional correlation of ADAMTS13. Curt Opin Hematol, 2007, 14(3): 270-276.
  • 2Bergmeier W, Chauhan AK, Wagner DD. Glycoprotein Ibalpha and von Willebrand factor in primary platelet adhesion and thrombus formation: lessons from mutant mice. Thromb Haemost, 2008, 99(2): 264-270.
  • 3Tsai HM. Thrombotic thrombocytopenic purpura: a thrombotic disorder caused by ADAMTS13 deficiency.Hematol Oncol Clin North Am, 2007, 21(4): 609-632.
  • 4Zheng XL, Sadler JE. Pathogenesis of thrombotic microangiopathies. Annu Rev Pathol, 2008, 3: 249-277.
  • 5Desch KC, Motto DG. Thrombotic thrombocytopenic purpura in humans and mice. Arterioscler Thromb Vasc Biol, 2007, 27(9): 1901-1908.
  • 6Levy GG, Nichols WC, Lian EC, et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature, 2001, 413(6855): 488-494.
  • 7Tsai HM. Current concepts in thrombotic thrombocytopenic purpura. Annu Rev Med, 2006, 57: 419-436.
  • 8Tao Z, Peny Y, Nolasco L, et al. Recombinant CUB-1 domain polypeptide inhibits the cleavage of ULVWFstrings by ADAMTS13 under flow conditions. Blood, 2005, 106(13): 4139-4145.
  • 9Zhou W, Tsai HM. An enzyme immunoassay of ADAMTS13 distinguishes patients with thrombotic thrombocytopenic purpura from normal individuals and carriers of ADAMTS 13 mutations. Thromb Haemost, 2004, 91(4): 806-811.
  • 10Tsai HM. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood, 1996, 87(10): 4235-4244.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部